Lucas Tien Wee Luk

Insider Reports History

Location
Singapore, Singapore
Signature
/s/ Lucas Tien Wee Luk
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lucas Tien Wee Luk:

Company Role Class Num Shares Value Price $ Report Date Ownership
CytoMed Therapeutics Ltd Chief Clinical Officer, Director Ordinary Shares, no par value per share 92,563 31 Mar 2023 Direct

Insider Reports Filed by Lucas Tien Wee Luk

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GDTC CytoMed Therapeutics Ltd 31 Mar 2023 0 $0 3 Chief Clinical Officer, Director 14 Apr 2023, 16:58